LENZ Therapeutics (LENZ) Tax Provisions (2024 - 2025)
LENZ Therapeutics' (LENZ) quarterly Tax Provisions came in at $2000.0 in Q4 2025, up 100.0% year-on-year from $1000.0 in Q4 2024, and down 99.6% on a QoQ basis from $500000.0 in Q2 2025.
LENZ Therapeutics (LENZ) Tax Provisions (2024 - 2025) Analysis & Trends
LENZ Therapeutics (LENZ) has 2 years of Tax Provisions data on file, last reported at $2000.0 in Q4 2025.
- On a quarterly basis, Tax Provisions rose 100.0% year-over-year to $2000.0 in Q4 2025; TTM through Dec 2025 was $503000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $502000.0, up 50100.0% from the prior year.
- Tax Provisions for Q4 2025 stood at $2000.0, down from $500000.0 in the prior quarter.
- Over the last five years, Tax Provisions for LENZ reached as high as $500000.0 in Q2 2025 and fell as low as $1000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | LENZ Therapeutics | 177.61 Mn | -80.77 Mn | 825,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2,000.00 |
| Jun 30, 2025 | 500,000.00 |
| Dec 31, 2024 | 1,000.00 |